Don't want ads? Subscribe or login now.

Zymergen Ch. 11 Plan Confirmed After Investor Objection

By Ben Zigterman · February 5, 2024, 5:09 PM EST

Biotechnology company Zymergen received confirmation of its Chapter 11 plan Monday at a hearing in Delaware bankruptcy court after resolving an objection to the plan from a class of investors suing...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Zymergen Inc.

Case Number

1:23-bk-11661

Court

Delaware

Nature of Suit

Date Filed

October 03, 2023

Recent Articles By Ben

April 22, 2024
Ebix Can Use Proceeds Of $386M Sale To Pay Down Debt
April 09, 2024
Ch. 11 Judge Tosses Calif. Drug Co.'s Bid To Stay Investor Suit
February 13, 2024
Kidde-Fenwal Row Not For Bankruptcy Court, Insurers Say
January 25, 2024
Eye Care Tech Co. Gets Tentative OK For $8M DIP
January 23, 2024
Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says
January 10, 2024
Celsius Insurers Seek OK To Pay Execs' Defense Costs
December 01, 2023
LA Airports' Bid For COVID Coverage Sunk By Federal Judge
November 13, 2023
Kidde-Fenwal Seeks Insurance Coverage For Foam Claims
November 02, 2023
3rd Circ. Rejects Bids To Freeze Boy Scouts' Ch. 11 Plan
October 31, 2023
Adjuster Wants Out Of Apartment's Ida Damage Coverage Suit